)

Andrea Salmen
COO,
NEOGAP Therapeutics
Andrea is a highly experienced professional in the biopharmaceutical industry. She has a background in process development and manufacturing of biologics for clinical trials, and more recently she has also gained in depth experience from clinical trial management. Her career has included roles as a Project Manager at CDMO Cobra Biologics, as well as positions at AstraZeneca and Recipharm.
Sessions
-
04-Sep-2025PlenaryInnovation exchange